• 2015

Company Description

TargEDys Develops New Microbiome-based Solutions for Appetite Regulation

SAS TargEDys develops mechanisms involving hormone mimetic proteins linked to microbiota for the treatment of eating disorders such as hyperphagia or anorexia. The company was incorporated in 2011 and is based in Rouen, Fran